NCT03487588View on ClinicalTrials.gov

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 21, 2018

Primary Completion Date

November 14, 2018

Study Completion Date

November 14, 2018

Conditions
Seborrheic Keratosis
Interventions
DRUG

A-101 Topical Solution

A-101 Topical Solution applied Day 1, Day 15 and Day 29

Trial Locations (3)

19034

Aclaris Investigational Site, Fort Washington

37922

Aclaris Investigational Site, Knoxville

78759

Aclaris Investigational Site, Austin

Sponsors
All Listed Sponsors
lead

Aclaris Therapeutics, Inc.

INDUSTRY

NCT03487588 - An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses | Biotech Hunter | Biotech Hunter